Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

360

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

August 31, 2013

Conditions
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer
Interventions
DRUG

capecitabine

OTHER

clinical observation

PROCEDURE

adjuvant therapy

Trial Locations (46)

SS16 5NL

Basildon University Hospital, Basildon

RG24 9NA

Basingstoke and North Hampshire NHS Foundation Trust, Basingstoke

B15 2TT

Cancer Research UK Clinical Trials Unit - Birmingham, Birmingham

BH7 7DW

Royal Bournemouth Hospital, Bournemouth

BS2 8ED

Bristol Haematology and Oncology Centre, Bristol

CB2 2QQ

Addenbrooke's Hospital, Cambridge

CV2 2DX

Walsgrave Hospital, Coventry

CM20 1QX

Princess Alexandra Hospital, Essex

GU2 7XX

St. Luke's Cancer Centre at Royal Surrey County Hospital, Guildford

HX3 0PW

Calderdale Royal Hospital, Halifax

HD3 3EA

Huddersfield Royal Infirmary, Huddersfield, West Yorks

LS16 6QB

Cancer Research UK Clinical Centre at St. James's University Hospital, Leeds

LE1 5WW

Leicester Royal Infirmary, Leicester

LE5 4PW

Leicester General Hospital, Leicester

L7 8XP

Royal Liverpool University Hospital, Liverpool

L9 7AL

Aintree University Hospital, Liverpool

EC1A 7BE

Saint Bartholomew's Hospital, London

N18 1QX

Helen Rollason Cancer Care Centre at North Middlesex Hospital, London

NW3 2QG

UCL Cancer Institute, London

SE1 7EH

St. Thomas' Hospital, London

SE5 9RS

King's College Hospital, London

SW3 6JJ

Royal Marsden - London, London

W12 OHS

Hammersmith Hospital, London

WIT 3AA

University College of London Hospitals, London

ME16 9QQ

Maidstone Hospital, Maidstone

M20 4BX

Christie Hospital, Manchester

M8 6RB

North Manchester General Hospital - Penine Actute Hospitals Trust, Manchester

CH63 4JY

Clatterbridge Centre for Oncology, Merseyside

NE4 6BE

Northern Centre for Cancer Treatment at Newcastle General Hospital, Newcastle upon Tyne

NE7 7DN

Freeman Hospital, Newcastle upon Tyne

PO30 5TG

St. Mary's Hospital, Newport

NG5 1PB

Nottingham City Hospital, Nottingham

PL6 8DH

Derriford Hospital, Plymouth

PO3 6AD

Portsmouth Oncology Centre at Saint Mary's Hospital, Portsmouth Hants

B98 7UB

Alexandra Healthcare NHS, Redditch, Worcestershire

SP2 8BJ

Salisbury District Hospital, Salisbury

S1O 2SJ

Cancer Research Centre at Weston Park Hospital, Sheffield

SO16 6YD

Southampton General Hospital, Southampton

SM2 5PT

Royal Marsden - Surrey, Sutton

SS0 0RY

Southend University Hospital NHS Foundation Trust, Westcliff-on-Sea

BA21 4AT

Yeovil District Hospital, Yeovil

DD1 9SY

Ninewells Hospital, Dundee

EH4 2XU

Edinburgh Cancer Centre at Western General Hospital, Edinburgh

G12 0YN

Beatson West of Scotland Cancer Centre, Glasgow

PH1 1NX

Perth Royal Infirmary, Perth

CF14 2TL

Velindre Cancer Center at Velindre Hospital, Cardiff

All Listed Sponsors
lead

University Hospital Southampton NHS Foundation Trust

OTHER

NCT00363584 - Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancer | Biotech Hunter | Biotech Hunter